Dr. Woltering is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Esplanade Ave
Sutie 200
Kenner, LA 70065Phone+1 504-464-8500Fax+1 504-646-8525
Education & Training
- Vanderbilt University Medical CenterResidency, Surgery, 1979 - 1982
- Vanderbilt University Medical CenterResidency, Surgery, 1975 - 1977
- Ohio State University College of MedicineClass of 1975
Certifications & Licensure
- LA State Medical License 1993 - 2022
- OH State Medical License 1975 - 2021
- OR State Medical License 1986 - 2021
- MD State Medical License 1978 - 1983
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627) Start of enrollment: 2004 Nov 01
Publications & Presentations
PubMed
- 10 citationsCdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors.Angela M. Carter, Nilesh Kumar, Brendon Herring, Chunfeng Tan, Rachael Guenter
Oncogenesis. 2021-12-03 - 4 citationsManagement of Appendiceal Neuroendocrine Tumors: Metastatic Potential of Small Tumors.Jace P. Landry, Brianne A. Voros, Robert A. Ramirez, J. Philip Boudreaux, Eugene A. Woltering
Annals of Surgical Oncology. 2021-02-01 - 20 citationsPhosphoprotein-based biomarkers as predictors for cancer therapy.Angela M. Carter, Chunfeng Tan, Karine Pozo, Rahul Telange, Roberto Molinaro
Proceedings of the National Academy of Sciences of the United States of America. 2020-08-04
Grant Support
- Three Chemotherapy Regimens In Women With Node-Positive Breast CancerNational Center For Research Resources2006
- Angiogenic Endothelial Cell Detection In Peripheral Circulation In Metastatic DSNational Center For Research Resources2006
- Trial To Compare Adjuvant Adriamycin And Cyclophosphamide In Breast Cancer PTSNational Center For Research Resources2005–2006
- Trial Comparing SIX Cyles Of Fec To Four Cycles Of AC In Breast CancerNational Center For Research Resources2005–2006
- Trial Comparing Adjuvant Clodronate Therapy Versus Placebo Early Breast CancerNational Center For Research Resources2005–2006
- Trial Comparing 5-FU PLUS Leucovorin And Oxaliplatin In Carcinoma Of The ColonNational Center For Research Resources2005–2006
- NSABP B-27:Trial Comparing Preop AC To AC Followed By Taxotere/Cancer Of BreastNational Center For Research Resources2004–2006
- Trial Comparing Ac-T To Ac-T+H In Node-Positive Breast Cancer PatientsNational Center For Research Resources2005
- Trial To Compare Adjuvant Adriamycin &CyclophosphamideNational Center For Research Resources2004
- Trial Comparing Adjuvant Clodronate Therapy VS PlaceboNational Center For Research Resources2004
- Trial Comparing Ac-T To Ac-T+H In Node+ Breast CancerNational Center For Research Resources2004
- Trial Comparing 5-FU PLUS Leucovorin And OxaliplatinNational Center For Research Resources2004
- Octreotide PLUS Tamoxifen In Breast CancerNational Center For Research Resources2000–2001
- Nsabp28--Worth Of Taxol Following Adriamycin In Breast CancerNational Center For Research Resources2000–2001
- NSABP B-27--Trial Comparing Preop AC To AC Followed By Taxotere In Breast CancerNational Center For Research Resources2000–2001
- NSABP B 23--Short Intensive Ac/Tamoxifen W/ CMP PLUS Tamoxifen In Breast CancerNational Center For Research Resources2000–2001
- High Dose Radioactive Iodine-Labeled Somatostatin Analogs For CancerNational Center For Research Resources1998–1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: